tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SGMT Stock Latest News

Sagimet Biosciences, Inc.: Promising Pipeline and Strong Financial Position Justify Buy Rating
RatingsSagimet Biosciences, Inc.: Promising Pipeline and Strong Financial Position Justify Buy Rating
4d ago
SGMT
Sagimet Biosciences price target raised to $35 from $33 at Citizens JMP
PremiumThe Fly
Sagimet Biosciences price target raised to $35 from $33 at Citizens JMP
7d ago
SGMT
Sagimet Biosciences Reports Q3 2025 Financial Results
PremiumCompany Announcements
Sagimet Biosciences Reports Q3 2025 Financial Results
7d ago
SGMT
Optimistic Buy Rating for Sagimet Biosciences Driven by Promising Clinical Progress and Strong Financial Position
PremiumRatings
Optimistic Buy Rating for Sagimet Biosciences Driven by Promising Clinical Progress and Strong Financial Position
8d ago
SGMT
Sagimet Biosciences Reports Q3 Results and Updates
PremiumCompany Announcements
Sagimet Biosciences Reports Q3 Results and Updates
8d ago
8K
SGMT
Sagimet Biosciences reports Q3 EPS (40c), consensus (39c)
PremiumThe FlySagimet Biosciences reports Q3 EPS (40c), consensus (39c)
8d ago
SGMT
Sagimet Biosciences presents two denifanstat posters at AASLD
Premium
The Fly
Sagimet Biosciences presents two denifanstat posters at AASLD
11d ago
SGMT
Sagimet Biosciences, Inc. Class A (SGMT) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Sagimet Biosciences, Inc. Class A (SGMT) Q3 Earnings Cheat Sheet
11d ago
SGMT
Sagimet Biosciences announces denifanstat met all primary, secondary endpoints
PremiumThe Fly
Sagimet Biosciences announces denifanstat met all primary, secondary endpoints
28d ago
SGMT
Sagimet Biosciences Highlights Drug Development Success
PremiumCompany Announcements
Sagimet Biosciences Highlights Drug Development Success
29d ago
8K
SGMT
Sagimet Biosciences initiated with a Buy at Clear Street
PremiumThe Fly
Sagimet Biosciences initiated with a Buy at Clear Street
1M ago
MDGL
SGMT
Sagimet Biosciences to present Phase 2b FASCINATE-2 study results
PremiumThe Fly
Sagimet Biosciences to present Phase 2b FASCINATE-2 study results
2M ago
SGMT
Buy Rating for Sagimet Biosciences: Promising Clinical Developments and Synergistic Therapy Potential
PremiumRatingsBuy Rating for Sagimet Biosciences: Promising Clinical Developments and Synergistic Therapy Potential
2M ago
SGMT
Sagimet announces dosing in Phase 1 PK trial of denifanstat with resmetirom
Premium
The Fly
Sagimet announces dosing in Phase 1 PK trial of denifanstat with resmetirom
2M ago
SGMT
Sagimet Biosciences reports data from Phase 3 trial on denifanstat
Premium
The Fly
Sagimet Biosciences reports data from Phase 3 trial on denifanstat
2M ago
SGMT
Sagimet Biosciences announces presentations at MASH Drug Development Summit
PremiumThe Fly
Sagimet Biosciences announces presentations at MASH Drug Development Summit
2M ago
SGMT
Promising Clinical Developments and Strategic Positioning Make Sagimet Biosciences a Buy
PremiumRatings
Promising Clinical Developments and Strategic Positioning Make Sagimet Biosciences a Buy
3M ago
SGMT
Promising Growth Potential of Sagimet Biosciences: Buy Rating Justified by Strategic Trials and Strong Financial Position
PremiumRatings
Promising Growth Potential of Sagimet Biosciences: Buy Rating Justified by Strategic Trials and Strong Financial Position
3M ago
SGMT
Promising Potential of Sagimet Biosciences’ FASN Inhibitors Drives Buy Rating
PremiumRatings
Promising Potential of Sagimet Biosciences’ FASN Inhibitors Drives Buy Rating
3M ago
SGMT
Sagimet Biosciences: Promising Advancements in FASN Inhibitor Platform and Strategic Growth Initiatives Justify Buy Rating
PremiumRatingsSagimet Biosciences: Promising Advancements in FASN Inhibitor Platform and Strategic Growth Initiatives Justify Buy Rating
3M ago
SGMT
Sagimet Biosciences Reports Progress in Acne and MASH Trials
Premium
Company Announcements
Sagimet Biosciences Reports Progress in Acne and MASH Trials
3M ago
SGMT
Sagimet Biosciences Enters New Sales Agreement with Leerink
Premium
Company Announcements
Sagimet Biosciences Enters New Sales Agreement with Leerink
3M ago
8K
SGMT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >